Reduced levels of Cav-1 in skin and dermal fibroblasts from SSc patients and in lung samples from ILD-SSc patientsReduction of Cav-1 in lung fibroblasts and lung tissue in bleomycin-induced IPF. This evidence concerns the gene CAV1 and systemic sclerosis.